Inogen | INGN - Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Accuray USD 100K 1000 2024-09
AngioDynamics USD 385K 1000 2025-02
AtriCure USD 49.7M 10K 2025-09
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 1.46B 2025-06
Chart Industries USD 44.95M 7K 2025-09
Cooper Companies USD 198.81M 9K 2025-09
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Globus Medical USD 135.06M 449K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 116K 2025-09
Orthofix International USD 3.82M 17K 2024-09
Philips EUR 951.29M 310K 2025-12
ResMed USD 145.97M 25K 2025-12
Steris USD 98.15M 344K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
X T L Biopharmaceuticals USD 881.39M 858.25M 2025-06
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12